ATX-968

N/A

Report date: 2024/04/26 11:49:43
NMEFirst In Class

Base Information

Drug NameATX-968
Drug Alias NameDHX9 protein inhibitor (Accent Therapeutics)ATX-968
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionATP-dependent RNA helicase A inhibitors
TargetsATP-dependent RNA helicase A
Therapy Area/IndicationsEndometrial NeoplasmsOvarian NeoplasmsColorectal Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAccent Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAccent Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsEndometrial NeoplasmsOvarian NeoplasmsColorectal Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A